Natera Has Acquired From Invitae Certain Assets Relating To Invitae's Non-invasive Prenatal Screening And Carrier Screening Business, For An Upfront Payment Of $10M. In Addition, The Transaction Includes $42.5M In Potential Milestone Payments
Portfolio Pulse from Benzinga Newsdesk
Natera, Inc. has acquired assets related to non-invasive prenatal screening and carrier screening from Invitae Corporation for an upfront payment of $10 million. The deal also includes up to $42.5 million in potential milestone payments.
January 22, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Natera's acquisition of prenatal screening assets from Invitae could enhance its product offerings and market share, with an initial investment of $10M and future milestone payments.
The acquisition is likely to be viewed positively as it expands Natera's product line and could lead to increased market share and revenue in the prenatal screening sector. The upfront cost is relatively modest with additional milestone payments tied to performance, suggesting a strategic growth move.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Invitae has sold part of its prenatal and carrier screening business to Natera for $10M upfront, with the possibility of receiving $42.5M more based on milestones.
The impact on Invitae's stock is uncertain. The sale could be seen as a strategic move to focus on core competencies or as a need for cash. The potential for future milestone payments adds a positive element, but the immediate financial impact is limited.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70